Literature DB >> 7260095

Isolation and further characterization of bovine brain hexosaminidase C.

B Overdijk, W M Van der Kroef, G J Van Steijn, J J Lisman.   

Abstract

Hexosaminidase C (2-acetamido-2-deoxy-beta-D-glucoside acetamidodeoxyglucohydrolase, EC 3.2.1.30) was partially purified from bovine brain tissue. The resulting preparation, free of its lysosomal counterparts, was used for the characterization of the enzyme and for further purification (lectin affinity chromatography, hydrophobic interaction chromatography, substrate-ligand affinity chromatography, ion-exchange chromatography, chromatography on activated thiol-Sepharose 4B). Only ion-exchange chromatography on DEAE-Sephacel appeared to improve the purity. The Michaelis constant was 0.46 mM for the substrate 4-methyl-umbelliferyl-2-acetamido-2-deoxy-beta-D-glucopyranoside. The enzyme was not inhibited by acetate or N-acetylgalactosamine. Inhibition by N-acetylglucosamine was competitive, with a Ki value of 8.0 mM. Inhibition by divalent metal ions increased in the order Fe less than Zn less than Cu. Dithiothreitol and beta-mercaptoethanol, at an optimum concentration of about 10 mM, stimulated the activity. The enzyme is apparently not a glycoprotein since it did not bind to various lectins, nor did sialidase change its isoelectric point.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7260095     DOI: 10.1016/0005-2744(81)90052-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins.

Authors:  K P Kearse; G W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

2.  Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes.

Authors:  Tracey M Gloster; David J Vocadlo
Journal:  Curr Signal Transduct Ther       Date:  2010-01

Review 3.  O-Linked β-N-acetylglucosamine (O-GlcNAc) modification: a new pathway to decode pathogenesis of diabetic retinopathy.

Authors:  Zafer Gurel; Nader Sheibani
Journal:  Clin Sci (Lond)       Date:  2018-01-19       Impact factor: 6.124

Review 4.  Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.

Authors:  Gerald W Hart; Chad Slawson; Genaro Ramirez-Correa; Olof Lagerlof
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

5.  O-GlcNAcase Fragment Discovery with Fluorescence Polarimetry.

Authors:  Vladimir S Borodkin; Karim Rafie; Nithya Selvan; Tonia Aristotelous; Iva Navratilova; Andrew T Ferenbach; Daan M F van Aalten
Journal:  ACS Chem Biol       Date:  2018-05-02       Impact factor: 5.100

Review 6.  O-GlcNAcylation and neurodegeneration.

Authors:  Willayat Y Wani; John C Chatham; Victor Darley-Usmar; Lori L McMahon; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2016-08-04       Impact factor: 4.077

7.  Molecular modeling and analysis of human and plant endo-β-N-acetyl- glucosaminidases for mutations effects on function.

Authors:  Shechinah Felice Choragudi; Ganesh Kumar Veeramachaneni; Bv Raman; Bondili Js
Journal:  Bioinformation       Date:  2014-08-30

Review 8.  Three Decades of Research on O-GlcNAcylation - A Major Nutrient Sensor That Regulates Signaling, Transcription and Cellular Metabolism.

Authors:  Gerald W Hart
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-27       Impact factor: 5.555

9.  SIRT1 regulates O-GlcNAcylation of tau through OGT.

Authors:  Shu Lu; Xiaomin Yin; Jia Wang; Qun Gu; Qin Huang; Nana Jin; Dandan Chu; Ziqi Xu; Fei Liu; Wei Qian
Journal:  Aging (Albany NY)       Date:  2020-04-20       Impact factor: 5.682

Review 10.  O-GlcNAcylation: key regulator of glycolytic pathways.

Authors:  Zachary A Bacigalupa; Chaitali H Bhadiadra; Mauricio J Reginato
Journal:  J Bioenerg Biomembr       Date:  2018-01-18       Impact factor: 3.853

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.